Ruttenberg Treatment Center — New York, New York

Ruttenberg Treatment Center is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Ruttenberg Treatment Center has participated in 4 clinical trials with 3 currently active.

Therapeutic areas: Primary Myelofibrosis, MPN-associated Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis.

Sponsors: Celgene, John Mascarenhas, Icahn School of Medicine at Mount Sinai.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ruttenberg Treatment Center?

Ruttenberg Treatment Center has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ruttenberg Treatment Center conducted?

Ruttenberg Treatment Center has 4 clinical trials on record, with 3 currently active. Their work covers Primary Myelofibrosis, MPN-associated Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis.

Is Ruttenberg Treatment Center accredited by Crixeo Health?

Ruttenberg Treatment Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ruttenberg Treatment Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.